| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Chief Business Officer | Common Stock | 0 | $0 | $6.33 | 20 May 2024 | Direct |
| ALPINE IMMUNE SCIENCES, INC. | Chief Business Officer | Stock Option (Right to buy) | 0 | 20 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000162619924000090-durand-remy-2024-05-20 | ALPINE IMMUNE SCIENCES, INC. | 20 May 2024 | 8 | $0 | 4 | Chief Business Officer | 20 May 2024, 20:02 |
| /report/000162619924000074-durand-remy-2024-05-08 | ALPINE IMMUNE SCIENCES, INC. | 08 May 2024 | 10 | +$513,869 | 4 | Chief Business Officer | 10 May 2024, 19:25 |
| /report/000162619924000022-durand-remy-2024-01-04 | ALPINE IMMUNE SCIENCES, INC. | 04 Jan 2024 | 2 | $0 | 4 | Chief Business Officer | 05 Jan 2024, 18:06 |
| /report/000162619923000061-durand-remy-2023-04-21 | ALPINE IMMUNE SCIENCES, INC. | 21 Apr 2023 | 0 | $0 | 3 | Chief Business Officer | 27 Apr 2023, 15:58 |